| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2774446 | Endocrinología y Nutrición | 2007 | 7 Pages |
Abstract
The response of these tumors to conventional chemotherapy is limited. The development of studies with antiangiogenic drugs, epidermic growth factor receptor inhibitors, and mTOR inhibitors probably represents a significant advance in the treatment of neuroendocrine tumors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
MarÃa Ausencia Tomé, Ignacio Durán, Ramón Salazar, José Ángel DÃaz,